Research in the IMSR is systematically translated into health and generation of long-lasting impact including Intellectual Property generation and industry collaborations.
To link our research with the resources and expertise in the National Health Service we have created translational centres in collaboration with Birmingham Health Partners (BHP), bringing together the researchers from the University of Birmingham with colleagues from the University Hospital Birmingham (UHB), Birmingham Women’s Hospital (BWH) and Birmingham Children’s Hospital (BCH) NHS Foundation Trusts.
- BHP Centre for Endocrinology, Diabetes and Metabolism (CEDAM) (Lead: Professor Neil Gittoes)
- BHP Centre for Maternal and Newborn Health ( Lead: Professor Mark Kilby)
- Tommy’s National Centre for Miscarriage Research, spanning three Universities (Birmingham, Warwick and Imperial College; Director: Professor Arri Coomarasamy)
IMSR research is also translated into health through the activities of the MRC ARUK Centre for Musculoskeletal Ageing and the NIHR Trauma Centre .
We lead unique cohort studies and pioneering clinical trials across the spectrum of metabolic, endocrine and reproductive disease, with a special focus on rare metabolic and endocrine disease, in interaction with the Rare Disease Centre at the Institute of Translational Medicine (ITM).